Tilray, a cannabis company, has seen its stock price drop by 8.16% over the past week. This decline comes amidst the company’s plans to undertake a reverse stock split to preven ...

Struggling cannabis company Tilray Brands (TLRY) is planning to undertake a reverse stock split.Stay Ahead of the Market: ...

Tilray shares are trading lower by 6.2% during Thursday's session. The company on Thursday announced plans to implement a reverse stock split.

Tilray Brands (NasdaqGS:TLRY) has called for a special stockholder meeting to discuss a potential reverse stock split, with ratios ranging from 1-for-10 to 1-for-20 being proposed. Over the past week, ...

Tilray has also reported a reduction in its total debt outstanding by approximately $76 million during the fiscal year 2025 ...

Tilray Brands Inc. (NASDAQ: TLRY) has launched its first medical cannabis edibles in Australia through Tilray Medical. The ...

Tilray Brands Inc. said Thursday it’s planning to seek shareholder approval for a reverse stock split as dramatic as 20-for-1 ...

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Beverages, the U.S. beverage division of Tilray Brands, Inc. (NASDAQ: ...

Good Supply Pastilles are available in the following options: Medical cannabis patients are now able to purchase the Good Supply Pastilles in packs of 60 from Tilray Direct or their local medical ...

Tilray Brands, Inc. ("Tilray" or "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the ...

Galmed Pharmaceuticals Ltd. ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company, today announced a sponsored research collaboration with Virginia Commonwealth University (VCU) to ...

Profound Medical Corp. ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, ...